Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Top Research Reports for Intuit, Diageo & Sony
08:16pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Today's Research Daily features new research reports on 12 major stocks, including Intuit Inc. (INTU), Diageo plc (DEO) and Sony Group Corp. (SONY).
Earnings Preview: LeMaitre Vascular (LMAT) Q3 Earnings Expected to Decline
02:02pm, Thursday, 20'th Oct 2022 Zacks Investment Research
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?
02:01pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What 7 Analyst Ratings Have To Say About Boston Scientific
03:09pm, Tuesday, 18'th Oct 2022 Benzinga
Analysts have provided the following ratings for Boston Scientific (NYSE:BSX) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
4
0
0
0
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
02:21pm, Tuesday, 18'th Oct 2022 Benzinga
Upgrades
According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur
Will Boston Scientific (BSX) Beat Q3 Earnings Estimates?
04:15pm, Monday, 17'th Oct 2022 Zacks Investment Research
Boston Scientific's (BSX) top line is likely to have improved with non-COVID elective medical procedures running in a full-fledged way in the United States and across the globe.
Why Boston Scientific (BSX) Could Beat Earnings Estimates Again
04:10pm, Monday, 17'th Oct 2022 Zacks Investment Research
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Boston Scientific (BSX) Could Beat Earnings Estimates Again
01:33pm, Monday, 17'th Oct 2022
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Boston Scientific (BSX) Beat Q3 Earnings Estimates?
01:33pm, Monday, 17'th Oct 2022
Boston Scientific's (BSX) top line is likely to have improved with non-COVID elective medical procedures running in a full-fledged way in the United States and across the globe.
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
02:02pm, Wednesday, 12'th Oct 2022 Benzinga
Upgrades
For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte
Boston Scientific Announces Conference Call Discussing Third Quarter 2022 Results
09:30am, Monday, 03'rd Oct 2022
MARLBOROUGH, Mass. , Oct. 3, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter
Boston Scientific (BSX) Benefits From New Buyouts, FX Woes Stay
03:01pm, Tuesday, 27'th Sep 2022 Zacks Investment Research
Boston Scientific's (BSX) organic growth performance is strong across all regions where most of its businesses are growing at the same pace or faster than their competitors in the respective markets.
Boston Scientific (BSX) Benefits From New Buyouts, FX Woes Stay
12:02pm, Tuesday, 27'th Sep 2022
Boston Scientific's (BSX) organic growth performance is strong across all regions where most of its businesses are growing at the same pace or faster than their competitors in the respective markets.
Here's Why You Should Retain Boston Scientific (BSX) For Now
04:11pm, Tuesday, 20'th Sep 2022 Zacks Investment Research
Investors are optimistic about Boston Scientific's (BSX) impressive top-line results and notable acquisitions.
Here's Why You Should Retain Boston Scientific (BSX) For Now
01:33pm, Tuesday, 20'th Sep 2022
Investors are optimistic about Boston Scientific's (BSX) impressive top-line results and notable acquisitions.
